CLOs on the Move

Examinetics

www.examinetics.com

 
We are the largest provider of onsite occupational health screening and data management services in the United States. Last year alone, over 1,700 clients asked us to test almost 1,000,000 people at more than 8,000 sites. We employ over 200 personnel,
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

LifeNet Health

LifeNet Health is a Virginia Beach, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cryo-Cell International

The mission of Cryo-Cell is to provide education and awareness on the vast potential benefits of stem cells and regenerative medicine to treat disease and save lives today and in the future.

Great Lakes Medical Research

Great Lakes Medical Research is a Westfield, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Issaquah Dental Laboratory

Issaquah Dental Lab is dedicated to providing a working environment which attracts & retains high quality technicians, staff, and clients. Issaquah Dental Lab's success is defined by an on going commitment to our co-workers, clients, suppliers, and

Natera

Natera Inc. is a genetic testing company that specializes in analyzing tiny quantities of DNA for reproductive health. Natera operates a CLIA-certified laboratory in San Carlos, Calif., providing a host of preconception and prenatal genetic testing services. Test offerings include pre-implantation genetic diagnosis to identify chromosomal anomalies or inherited genetic conditions in embryos generated during an IVF cycle; products-of-conception testing following miscarriage to analyze fetal chromosomes and understand the cause of the pregnancy loss; non-invasive prenatal testing to determine paternity; carrier screening to detect whether parents carry genetic variations that may result in disease in the child; and Panorama, a safe, simple test for pregnant women that identifies the most common chromosomal anomalies in a fetus as early as nine weeks of gestation. Natera's PreNATUS clinical trial for non-invasive screening of fetal chromosomal anomalies is funded by the NIH and is being conducted by the leaders in maternal-fetal medicine in the United States. These tests were developed by Natera, a laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). They have not been cleared or approved by the U.S. Food and Drug Administration (FDA). In August, Natera was selected by the World Economic Forum as a Technology Pioneer for innovations in prenatal care. For more information, visit www.natera.com.